Hubert S. Chou

Initial treatment with rosiglitazone/metformin fixed‐dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes

J Rosenstock, Julie A. Rood, Alexander R. Cobitz et al. · Diabetes Obesity and Metabolism · 2006 · 88 citations

Medicine, Pharmacology, Pharmacotherapy +17

Initial treatment with fixed‐dose combination rosiglitazone/glimepiride in patients with previously untreated type 2 diabetes

Hubert S. Chou, Jerry P. Palmer, Alma R. Jones et al. · Diabetes Obesity and Metabolism · 2007 · 32 citations

Medicine, Pharmacology, Pharmacotherapy +17

Effects of colesevelam on glucose absorption and hepatic/peripheral insulin sensitivity in patients with type 2 diabetes mellitus

Robert R. Henry, Vanita R. Aroda, Sunder Mudaliar et al. · Diabetes Obesity and Metabolism · 2011 · 30 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Glucose-lowering effects and safety of DS-8500a, a G protein-coupled receptor 119 agonist, in Japanese patients with type 2 diabetes: results of a randomized, double-blind, placebo-controlled, parallel-group, multicenter, phase II study

Nobuya Inagaki, Hubert S. Chou, Shuji Tsukiyama et al. · BMJ Open Diabetes Research & Care · 2017 · 16 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

A 26-week, placebo- and pioglitazone-controlled, dose-ranging study of rivoglitazone, a novel thiazolidinedione for the treatment of type 2 diabetes

Kenneth E. Truitt, Ronald Goldberg, Julio Rosenstock et al. · Current Medical Research and Opinion · 2010 · 13 citations

Pharmacy, Pharmacology, Pharmacotherapy +16